Pontus Dunér - Academia.edu (original) (raw)
Uploads
Papers by Pontus Dunér
Circulation Research, Jun 19, 2009
Journal of Biological Chemistry, Nov 1, 2020
IJC Heart & Vasculature, Mar 1, 2015
British Journal of Dermatology, Nov 1, 2019
Scientific Reports, Sep 8, 2015
JACC: Basic to Translational Science, Dec 1, 2019
Embo Molecular Medicine, Apr 19, 2012
Atherosclerosis, Aug 1, 2014
Vascular Pharmacology, Sep 1, 2006
Journal of Clinical Medicine Research, 2020
Journal of Biological Chemistry, May 1, 2018
Pflügers Archiv: European Journal of Physiology, Feb 15, 2019
Journal of the American Heart Association, Feb 4, 2020
Journal of Immunology, Mar 1, 2010
Scientific Reports, Apr 27, 2021
Cerebrovascular Diseases, 2016
Background: Galectin-3 (Gal-3) has been suggested to have both pro- and anti-atherogenic properti... more Background: Galectin-3 (Gal-3) has been suggested to have both pro- and anti-atherogenic properties. High plasma Gal-3 levels are associated with increased risk for cardiovascular (CV) death. However, it has so far not been investigated if plasma Gal-3 levels can predict the risk for future stroke in patients suffering from carotid atherosclerosis. The aim of this study was to investigate whether Gal-3 could be used as a marker to predict postoperative cerebrovascular ischemic events among patients who underwent carotid endarterectomy (CEA). Methods: Plasma samples were obtained from 558 CEA patients and Gal-3 levels were analyzed by the proximity extension assay technique. The Swedish national in-patient health register was used to identify postoperative cerebrovascular events during the follow-up period (42.6 ± 26.2 months). Results: Plasma Gal-3 was increased in patients treated for a symptomatic carotid stenosis (p = 0.013). Patients with Gal-3 levels above the median value had an increased incidence of stroke as shown by Kaplan-Meier curves of event-free survival (p = 0.007). Gal-3 was a predictor of postoperative stroke among women (hazard ratio 15.1, 95% CI 1.3-172.2; p = 0.028) even after correction for traditional CV risk factors. Conclusions: This study is the first to show that increased plasma levels of Gal-3 can help in predicting the occurrence of postoperative strokes among female subjects who undergo CEA, independently of traditional risk factors for cerebrovascular disease. This finding suggests that Gal-3 could be used as a marker to identify patients in need of intensified postoperative medical care.
Scientific Reports, Jun 16, 2017
Atherosclerosis, Oct 1, 2010
Circulation Research, Jun 19, 2009
Journal of Biological Chemistry, Nov 1, 2020
IJC Heart & Vasculature, Mar 1, 2015
British Journal of Dermatology, Nov 1, 2019
Scientific Reports, Sep 8, 2015
JACC: Basic to Translational Science, Dec 1, 2019
Embo Molecular Medicine, Apr 19, 2012
Atherosclerosis, Aug 1, 2014
Vascular Pharmacology, Sep 1, 2006
Journal of Clinical Medicine Research, 2020
Journal of Biological Chemistry, May 1, 2018
Pflügers Archiv: European Journal of Physiology, Feb 15, 2019
Journal of the American Heart Association, Feb 4, 2020
Journal of Immunology, Mar 1, 2010
Scientific Reports, Apr 27, 2021
Cerebrovascular Diseases, 2016
Background: Galectin-3 (Gal-3) has been suggested to have both pro- and anti-atherogenic properti... more Background: Galectin-3 (Gal-3) has been suggested to have both pro- and anti-atherogenic properties. High plasma Gal-3 levels are associated with increased risk for cardiovascular (CV) death. However, it has so far not been investigated if plasma Gal-3 levels can predict the risk for future stroke in patients suffering from carotid atherosclerosis. The aim of this study was to investigate whether Gal-3 could be used as a marker to predict postoperative cerebrovascular ischemic events among patients who underwent carotid endarterectomy (CEA). Methods: Plasma samples were obtained from 558 CEA patients and Gal-3 levels were analyzed by the proximity extension assay technique. The Swedish national in-patient health register was used to identify postoperative cerebrovascular events during the follow-up period (42.6 ± 26.2 months). Results: Plasma Gal-3 was increased in patients treated for a symptomatic carotid stenosis (p = 0.013). Patients with Gal-3 levels above the median value had an increased incidence of stroke as shown by Kaplan-Meier curves of event-free survival (p = 0.007). Gal-3 was a predictor of postoperative stroke among women (hazard ratio 15.1, 95% CI 1.3-172.2; p = 0.028) even after correction for traditional CV risk factors. Conclusions: This study is the first to show that increased plasma levels of Gal-3 can help in predicting the occurrence of postoperative strokes among female subjects who undergo CEA, independently of traditional risk factors for cerebrovascular disease. This finding suggests that Gal-3 could be used as a marker to identify patients in need of intensified postoperative medical care.
Scientific Reports, Jun 16, 2017
Atherosclerosis, Oct 1, 2010